Atlas Trials

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

Clinical trial NCT03960788 · UNKNOWN

Trial details

NCT number
NCT03960788
Sponsor
University of Cincinnati
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cancer of the ProstateCastration-resistant Prostate Cancer
Start date
2018-01-02
Primary completion
2020-01-02
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.